Oxford Biomedica PLC 2024 AR2
The report outlines Oxford Biomedica plc's (OXB) transition into a pure-play cell and gene therapy contract development and manufacturing organisation (CDMO) in 2024. During the year, the company achieved a 44% revenue growth to £128.8 million and delivered Operating EBITDA profitability in the second half of the year. On the environmental front, OXB achieved a 20% reduction in combined Scope 1 and 2 emissions compared to 2023 and sourced 51% of its electricity from renewable sources. The company also expanded its global footprint through the acquisition of ABL Europe (now OXB France) and successfully implemented its 'One OXB' strategy across the UK, US, and EU.
Company: Oxford Biomedica PLC
Sector: Professional & technical services
Country: United Kingdom
Year: 2024
Type: AR2
Pages: 178
Back to company
Oxford Biomedica PLC
Annual Report And Accounts
The report outlines Oxford Biomedica plc's (OXB) transition into a pure-play cell and gene therapy contract development and manufacturing organisation (CDMO) in 2024. During the year, the company achieved a 44% revenue growth to £128.8 million and delivered Operating EBITDA profitability in the second half of the year. On the environmental front, OXB achieved a 20% reduction in combined Scope 1 and 2 emissions compared to 2023 and sourced 51% of its electricity from renewable sources. The company also expanded its global footprint through the acquisition of ABL Europe (now OXB France) and successfully implemented its 'One OXB' strategy across the UK, US, and EU.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Net Zero Target
Employees